Sera Prognostics, Atreca spike after Baker Bros investments

seekingalpha

12 Jan 2024

Shares of Sera Prognostics (NASDAQ:SERA) and Atreca (NASDAQ:BCEL) traded higher on Thursday after hedge fund manager Baker Bros. Advisors disclosed investments in the companies.
According to 13G filings on Wednesday, the New York-based financial services firm has disclosed a passive stake of ~18% in Sera Prognostics (SERA), a Salt Lake City, Utah-based diagnostics firm focused on women's health.
Another SEC filing from Atreca (BCEL) indicated that Baker Bros.'s investment in the immunotherapy developer rose to ~20%, or ~7.7M shares, up from ~3.5M. The San Carlos, California-based nano-cap biotech develops antibody-based drugs for cancer.
According to other 13G reports filed by Baker Bros. on Wednesday, it has increased its stakes in Kymera Therapeutics (KYMR) and Replimune (REPL) to ~11% and ~16%, respectively.

More on Atreca, Sera Prognostics, etc.

Sera Prognostics: The Pregnancy Company On A Hot Streak
Sera Prognostics, Inc (SERA) Q3 2023 Earnings Call Transcript
Biggest stock movers today: Google, AMD, GameStop, C3.AI, Chewy and more
Sera Prognostics shares rocket 160% on PreTRM study update
Seeking Alpha’s Quant Rating on Atreca

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2402018724"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2402018724\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2402018724?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1294384963/image_1294384963.jpg","is_english":true,"pubTime":"2024-01-12 02:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2402018724","market":"us","top_or_hot":-1,"title":"Sera Prognostics, Atreca spike after Baker Bros investments","media":"seekingalpha","content":"<html><body><ul> <li>Shares of Sera Prognostics (<span>NASDAQ:SERA</span>) and <a href=\"https://laohu8.com/S/BCEL\">Atreca</a> (<span>NASDAQ:BCEL</span>) traded higher on Thursday after hedge fund manager Baker Bros. Advisors disclosed investments in the companies.</li> <li>According to 13G filings on Wednesday, the New York-based financial services firm has disclosed a passive stake of ~18%<span> in Sera Prognostics (</span>SERA<span>), a Salt Lake City, Utah-based diagnostics firm focused on women's health.</span> </li> <li>Another SEC filing from Atreca (BCEL) indicated that Baker Bros.'s investment in the immunotherapy developer rose to ~20%, or ~7.7M shares, up from ~3.5M. The San Carlos, California-based nano-cap biotech develops antibody-based drugs for cancer.</li> <li>According to other 13G reports filed by Baker Bros. on Wednesday, it has increased its stakes in Kymera Therapeutics (KYMR) and Replimune (REPL) to ~11% and ~16%, respectively.</li> </ul> <div> <h2>More on Atreca, Sera Prognostics, etc.</h2> <ul> <li>Sera Prognostics: The Pregnancy Company On A Hot Streak</li> <li>Sera Prognostics, Inc (SERA) Q3 2023 Earnings Call Transcript</li> <li>Biggest stock movers today: Google, AMD, GameStop, C3.AI, Chewy and more</li> <li>Sera Prognostics shares rocket 160% on PreTRM study update</li> <li>Seeking Alpha’s Quant Rating on Atreca</li> </ul> </div></body></html>","source":"seekingalpha_hot_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sera Prognostics, Atreca spike after Baker Bros investments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSera Prognostics, Atreca spike after Baker Bros investments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-01-12 02:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4054463-sera-prognostics-atreca-spike-baker-bros-stakes><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Sera Prognostics (NASDAQ:SERA) and Atreca (NASDAQ:BCEL) traded higher on Thursday after hedge fund manager Baker Bros. Advisors disclosed investments in the companies. According to 13G ...</p>\n\n<a href=\"https://seekingalpha.com/news/4054463-sera-prognostics-atreca-spike-baker-bros-stakes\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://seekingalpha.com/news/4054463-sera-prognostics-atreca-spike-baker-bros-stakes","article_id":"2402018724","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1294384963/image_1294384963.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2402018724","pubTimestamp":1704996537,"columns":[],"sourceInfo":{"source_id":"seekingalpha_hot_news","name":"SeekingAlpha"},"weMediaInfo":null,"summary":"Shares of Sera Prognostics  and Atreca  traded higher on Thursday after hedge fund manager Baker Bros. Advisors disclosed investments in the companies. According to 13G filings on Wednesday, the New York-based financial services firm has disclosed a passive stake of ~18% in Sera Prognostics , a Salt Lake City, Utah-based diagnostics firm focused on women's health.  Another SEC filing from Atreca  indicated that Baker Bros.'s investment in the immunotherapy developer rose to ~20%, or ~7.7M shares, up from ~3.5M. The San Carlos, California-based nano-cap biotech develops antibody-based drugs for cancer. According to other 13G reports filed by Baker Bros. on Wednesday, it has increased its stakes in Kymera Therapeutics  and Replimune  to ~11% and ~16%, respectively.   More on Atreca, Sera Prognostics, etc.  Sera Prognostics: The Pregnancy Company On A Hot Streak Sera Prognostics, Inc  Q3 2023 Earnings Call Transcript Biggest stock movers today: Google, AMD, GameStop, C3.AI, Chewy and more","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"Sera预测，贝克兄弟投资后Atreca飙升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{".IXIC":0.65,"BCEL":1,"MNQmain":0.6,"NQmain":0.6,"KYMR":1,"PSQ":0.6,"QID":0.6,"QLD":0.6,"QQQ":0.6,"REPL":1,"SERA":1,"SQQQ":0.6,"TQQQ":0.6},"content_text":"Shares of Sera Prognostics (NASDAQ:SERA) and Atreca (NASDAQ:BCEL) traded higher on Thursday after hedge fund manager Baker Bros. Advisors disclosed investments in the companies. According to 13G filings on Wednesday, the New York-based financial services firm has disclosed a passive stake of ~18% in Sera Prognostics (SERA), a Salt Lake City, Utah-based diagnostics firm focused on women's health.  Another SEC filing from Atreca (BCEL) indicated that Baker Bros.'s investment in the immunotherapy developer rose to ~20%, or ~7.7M shares, up from ~3.5M. The San Carlos, California-based nano-cap biotech develops antibody-based drugs for cancer. According to other 13G reports filed by Baker Bros. on Wednesday, it has increased its stakes in Kymera Therapeutics (KYMR) and Replimune (REPL) to ~11% and ~16%, respectively.   More on Atreca, Sera Prognostics, etc.  Sera Prognostics: The Pregnancy Company On A Hot Streak Sera Prognostics, Inc (SERA) Q3 2023 Earnings Call Transcript Biggest stock movers today: Google, AMD, GameStop, C3.AI, Chewy and more Sera Prognostics shares rocket 160% on PreTRM study update Seeking Alpha’s Quant Rating on Atreca","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}